Targeting the kinetochore for mitosis-specific inhibitors

9Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Microtubule poisons such as taxol and vinblastine are widely used to treat a variety of cancers. These drugs are believed to kill cells by blocking mitosis. However, there is a critical need to identify new drugs because tumors can often become refractory to treatment with existing drugs. Studies over the past decade on chromosome segregation have uncovered a plethora of novel proteins that function specifically in mitosis. Centrosomes and kinetochores are two organelles that specify formation of the spindle and the attachment of chromosomes to the spindle, respectively. The focus of this review is to highlight the kinetochore as a rich source of targets for the development of mitosis-specific drugs. ©2003 Landes Bioscience.

Author supplied keywords

Cite

CITATION STYLE

APA

Jablonski, S. A., Liu, S. T., & Yen, T. J. (2003, May). Targeting the kinetochore for mitosis-specific inhibitors. Cancer Biology and Therapy. https://doi.org/10.4161/cbt.2.3.384

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free